• LAST PRICE
    5.2500
  • TODAY'S CHANGE (%)
    Trending Up0.3713 (7.6106%)
  • Bid / Lots
    5.2100/ 3
  • Ask / Lots
    5.3500/ 7
  • Open / Previous Close
    4.9010 / 4.8787
  • Day Range
    Low 4.8150
    High 5.3500
  • 52 Week Range
    Low 3.9400
    High 136.5000
  • Volume
    76,795
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 4.8787
TimeVolumeZVSA
09:34 ET3334.9016
09:36 ET36004.9
09:45 ET17244.92
09:52 ET22004.93
09:57 ET8004.92
09:59 ET17185.0399
10:01 ET35905.0608
10:03 ET40555.1999
10:06 ET8005.182
10:08 ET22405.21
10:10 ET5425.2
10:12 ET12685.1123
10:14 ET16525.1429
10:17 ET6885.25
10:19 ET1005.2499
10:21 ET18485.2
10:24 ET10345.29
10:26 ET1005.2899
10:28 ET13935.2492
10:30 ET33985.35
10:33 ET12125.25
10:35 ET13995.2105
10:37 ET15005.2102
10:39 ET4005.22
10:42 ET1005.2194
10:48 ET19005.25
10:53 ET3505.2659
11:02 ET2975.2174
11:06 ET23125.2
11:08 ET1095.1829
11:15 ET6895.11
11:31 ET4985.1132
11:36 ET1005.15
11:38 ET2005.2009
11:40 ET7005.15
11:44 ET1005.24
11:45 ET3505.2
12:03 ET1305.1999
12:05 ET1005.15
12:07 ET2005.15
12:12 ET12465.15
12:14 ET3755.15
12:18 ET4785.1001
12:34 ET1005.0717
12:39 ET7054.95
12:43 ET1005.01
01:01 ET5005.05
01:17 ET5004.9854
01:21 ET25134.99
01:24 ET27185.0499
01:30 ET7335.05
01:42 ET1025.05
01:50 ET1065
02:24 ET4605.01
02:29 ET1005.0445
02:51 ET4465.03
02:58 ET7505.0572
03:18 ET16005.2096
03:20 ET12695.2097
03:21 ET4405.2099
03:25 ET7275.2
03:30 ET1255.1711
03:52 ET3035.21
03:56 ET7145.21
03:59 ET5545.25
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesZVSA
Zyversa Therapeutics Inc
4.4M
0.0x
---
United StatesARTL
Artelo Biosciences Inc
4.4M
-0.4x
---
United StatesTOVX
Theriva Biologics Inc
4.4M
-0.2x
---
United StatesNLSP
NLS Pharmaceutics AG
4.5M
-0.4x
---
United StatesVRAX
Virax Biolabs Group Ltd
4.3M
-1.2x
---
United StatesGNPX
Genprex Inc
4.6M
-0.1x
---
As of 2024-06-16

Company Information

ZyVersa Therapeutics, Inc. is a clinical-stage specialty biopharmaceutical company. The Company is focused on leveraging advanced technologies to develop drugs for patients with chronic renal or inflammatory diseases. Its lead renal drug candidate Cholesterol Efflux Mediator VAR 200 (2-hydroxypropyl-beta-cyclodextrin or 2HBCD) is in development to treat multiple renal indications. Its lead anti-inflammatory drug candidate, Inflammasome ASC Inhibitor IC 100, is a humanized monoclonal antibody in development to treat multiple inflammatory diseases. Its renal pipeline is initially focused on rare, chronic glomerular diseases. Its lead indication for VAR 200 is focal segmental glomerulosclerosis (FSGS). VAR 200’s active ingredient, 2HBCD, is comprised of seven sugar molecules bound together in a 3-D ring with a hydrophobic core and hydrophilic exterior. VAR 200 mediates cholesterol efflux both passively and actively by interacting with hydrophilic components of the glomerular membrane.

Contact Information

Headquarters
2200 N. Commerce Parkway, Suite 208WESTON, FL, United States 33326
Phone
754-231-1688
Fax
845-818-3588

Executives

Chairman of the Board, President, Chief Executive Officer, Co-Founder
Stephen Glover
Chief Financial Officer, Secretary
Peter Wolfe
Chief Medical Officer, Senior Vice President - Medical Affairs
Pablo Guzman
Chief Commercial Officer
Karen Cashmere
Independent Director
Robert Finizio

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.4M
Revenue (TTM)
$0.00
Shares Outstanding
834.9K
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1,791.54
Book Value
$27.33
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.